IICT, PI Industries join hands to manufacture Covid drug
Hyderabad: City-based Indian Institute of Chemical Technology (IICT), a constituent laboratory of Council of Scientific and Industrial Research (CSIR), is collaborating with PI Industries Limited and signed an agreement for technology transfer and manufacture of the anti-Covid drug 2-DG. In the last few months, especially after Drugs Controller General of India (DCGI) granted emergency use […]
Hyderabad: City-based Indian Institute of Chemical Technology (IICT), a constituent laboratory of Council of Scientific and Industrial Research (CSIR), is collaborating with PI Industries Limited and signed an agreement for technology transfer and manufacture of the anti-Covid drug 2-DG.
In the last few months, especially after Drugs Controller General of India (DCGI) granted emergency use authorisation for the anti-Covid drug, the institute has entered into similar collaborations with Anthem Biosciences, a Bengaluru-based integrated biopharmaceutical company, and Lee Pharma for synthesis of 2-DG. Under the terms of the license agreement, PI Industries Limited gets license for the process knowhow for synthesis of 2-DG (2-Deoxy-D-Glucose).
Dr Chandrasekhar, Director CSIR-IICT, said: “The agreement is in line with CSIR’s efforts to help people access various therapeutic options to combat Covid-19. CSIR labs have undertaken clinical trials of various repurposed drugs for the treatment of Covid-19.”
PI Industries Limited is in the process of filing the application for getting the approval from DCGI and will subsequently manufacture and commercialise 2-DG from their facilities.
Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.
Click to follow Telangana Today Facebook page and Twitter .
